Eledon Pharmaceuticals, Inc.
@Eledon_Pharma
Followers
330
Following
0
Media
222
Statuses
375
Targeting the CD40L pathway to develop potential treatments for organ or cell-based transplant, autoimmune and neurodegenerative diseases. $ELDN
Irvine, California
Joined December 2020
As part of our R&D Day event this year, $ELDN CSO Steven Perrin, Ph.D., reviewed the strategies we are exploring to support the prevention of transplant rejection, including targeting the CD40L pathway. Watch the full presentation to learn more: https://t.co/6grFwcrYgB
0
1
3
This National Liver Awareness Month, $ELDN stands with @liverUSA in highlighting the importance of expanding education on #LiverTransplantation while underscoring the need for innovation in immunosuppression to help protect transplanted livers. Learn more: https://t.co/9D2pacwMoN
0
1
4
#ICYMI During #WTC2025, we shared updated data from our Phase 1b clinical trial evaluating our investigational #immunosuppression therapy to prevent rejection in #KidneyTransplantation. Watch our webcast replay to learn more: https://t.co/W4NbyccwPU $ELDN
0
0
4
100k+ people in the U.S. are waiting for an #OrganTransplant, underscoring the urgent need for new solutions in #transplant medicine. Learn more about our work to address challenges impacting the lifespan of transplanted organs from $ELDN CEO @dalexgros: https://t.co/6grFwcsw69
0
2
8
For those attending #KidneyWk, we invite you to stop by our booth to meet our team and learn more about our work to achieve #OneTransplantForLife.
0
1
6
We are pleased to announce that we will present results from our Phase 2 BESTOW study at @ASNKidney's #KidneyWk. Join us to hear the latest updates from our research in #immunosuppression to help prevent rejection in #KidneyTransplantation: https://t.co/sHNTAARBvZ $ELDN
1
1
9
In an interview with Crushing T1, $ELDN CEO @dalexgros discusses our commitment to driving innovation in islet cell #transplantation to potentially support the management of type 1 #diabetes using our investigational #immunosuppression therapy. Watch here: https://t.co/SvkbFBO2jP
0
1
9
Thank you @ttsorg for the opportunity to contribute to critical conversations on the latest developments in #xenotransplantation while highlighting the need for innovation in #immunosuppression during the 18th Congress of the International Xenotransplantation Association. $ELDN
0
1
5
Joining @AST_info's Circle of Excellence reflects our commitment to supporting #LivingDonors and further aligns our workplace values with our mission to achieve #OneTransplantForLife. We’re proud to participate in this important program. $ELDN @ThePower2Save
We’re excited to welcome @Eledon_Pharma to AST’s Living Donor Circle of Excellence! 🌟 “The extraordinary generosity of living donors inspires our work at Eledon.” – Dr. Eliezer Katz, CMO Learn more about the program ➡️ https://t.co/mMtiqzxwht
0
1
5
We believe innovation in #immunosuppression therapy is essential to help address the challenging cycle that many patients experience as they transition from dialysis to #transplantation more than once during their lifetime. Learn more: https://t.co/KmoXidvUoL $ELDN
1
0
3
We are excited to share that $ELDN has proudly joined @AST_info’s Living Donor Circle of Excellence, a program recognizing companies with policies that financially support employees who become #LivingDonors. Learn more: https://t.co/BlogywWfBB
@ThePower2Save
0
0
5
This #DMVAppreciationMonth, we join @DonateLife in thanking DMV teams for their critical role in supporting #OrganDonor registrations. Through our work to advance research in #immunosuppression therapy to support #transplant recipients, we see their crucial impact.
0
0
4
For those attending, be sure to stop by our booth on the exhibit floor to connect with our team and learn more about our work to achieve #OneTransplantForLife through innovation in #immunosuppression therapy.
0
1
2
We're pleased to announce that $ELDN CSO Steven Perrin, Ph.D., will present at the International Xenotransplantation Association Conference to share insights on the role of anti-CD40L #immunosuppression therapy in #xenotransplantation. See details: https://t.co/8BldrkAuM6
@ttsorg
1
1
7
In a new episode of The Bio Report podcast hosted by @dslevine, $ELDN CSO Steve Perrin, Ph.D., discusses our research assessing strategies that may help extend the lifespan of transplanted kidneys through a new approach to #immunosuppression. Listen here:
podcasts.apple.com
Podcast Episode · The Bio Report · 09/17/2025 · 30m
Steve Perrin, CSO of @Eledon_Pharma, discusses the need for innovative approaches to immunosuppression in organ transplantation, how its experimental therapy works, and why it may have benefits in autoimmune and neurodegenerative diseases as well. https://t.co/7zJkMSOJ2v
0
1
9
At #CantorHCC, $ELDN CEO @dalexgros participated in a fireside chat to share updates on our work to drive innovation in #immunosuppression therapy for kidney allograft #transplantation. Watch the webcast replay: https://t.co/TkfyhzhWzE
0
1
5
This #OrganDonationWeek, we're proud to honor the lifesaving impact of #OrganDonors as we advance innovative #immunosuppression research to help prevent #transplant rejection and address the critical organ shortage crisis. Learn more from @NHSBT: https://t.co/4NHoMgNPyY $ELDN
nhsbt.nhs.uk
For this year's Organ Donation Week we want as many local landmarks and buildings across the country as possible to turn pink, to encourage people to confirm their support for organ donation by...
0
0
2
Through our work to advance #immunosuppression research for #transplant recipients, we see the critical support #NephrologyNurses provide across the #KidneyDisease community. Thank you for all that you do. @ANNAnurses $ELDN #NNW25
0
0
4
In this @renalandurology article covering important advances in #xenotransplantation, $ELDN CEO @dalexgros discusses the key role CD40L inhibition can play in potentially improving #immunosuppression protocols:
renalandurologynews.com
Is kidney xenotransplantation an answer to the kidney organ shortage? Experts weigh in the current promise and potential medical hurdles.
There is now a better understanding of the immunological and biological barriers between humans and pigs. Read our latest feature: https://t.co/3WGTHdwQsl
#kidneytransplant
0
1
6
We are grateful for the opportunity to partner with the teams at @MassGeneralNews and @eGenesisBio to support the third kidney #xenotransplant successfully performed at MGH using our investigational therapy, tegoprubart, as a key component of the #immunosuppression regimen. $ELDN
We’re proud to share 3 historic breakthroughs @mgh_transplant ✅3rd kidney xenotransplant completed at MGH — patient thriving at 90 days ✅7+ months dialysis-free: longest survival w/ a pig kidney ever ✅FDA clears larger trial @eGenesisBio
@MGHMedicine @MGHSurgery @MGBKidneys
0
1
10